Research reference only. Not medical advice. Most compounds are not FDA-approved. Consult a qualified clinician before any human use.

Anti-Aging & Longevity

FOXO4-DRI

FOXO4-D-Retro-Inverso

Classification: Senolytic peptide

Mechanism: Disrupts FOXO4-p53 binding in senescent cells; triggers selective apoptosis

Benefits: Senolytic (clears senescent cells); healthspan extension in aged mice

Evidence tier: Preclinical · Availability: Experimental

Primary sources

  1. Baar MP et al. Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging (FOXO4-DRI). Cell 2017. PMID 28340339
  2. Note: Preclinical evidence only — no published human clinical trials. Cited paper describes in-vitro or animal-model mechanism.

Loading interactive view…